• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于芳基喹啉羧酸骨架的具有抗拓扑异构酶活性的抑制剂。

Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti- Gyrase Activity.

机构信息

The Graduate School, University of Santo Tomas, España Blvd., Manila 1015, Philippines.

Laboratory for Organic Reactivity, Discovery and Synthesis (Rm. 410), Research Center for the Natural and Applied Sciences, University of Santo Tomas, Espana Blvd., Manila 1015, Philippines.

出版信息

Int J Mol Sci. 2023 Jul 19;24(14):11632. doi: 10.3390/ijms241411632.

DOI:10.3390/ijms241411632
PMID:37511390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380224/
Abstract

New antitubercular agents with either a novel mode of action or novel mode of inhibition are urgently needed to overcome the threat of drug-resistant tuberculosis (TB). The present study profiles new arylated quinoline carboxylic acids (QCAs) having activity against replicating and non-replicating (), the causative agent of TB. Thus, the synthesis, characterization, and in vitro screening (MABA and LORA) of 48 QCAs modified with alkyl, aryl, alkoxy, halogens, and nitro groups in the quinoline ring led to the discovery of two QCA derivatives, and adorned with C-2 2-(naphthalen-2-yl)/C-6 1-butyl and C-2 22-(phenanthren-3-yl)/C-6 isopropyl, respectively, as the best inhibitors. DNA gyrase inhibition was shown to be exhibited by both, with QCA illustrating better activity up to a 1 μM test concentration. Finally, a docking model for both compounds with DNA gyrase was developed, and it showed a good correlation with in vitro results.

摘要

新的抗结核药物,无论是具有新作用模式还是新抑制模式的药物,都迫切需要克服耐药性结核病(TB)的威胁。本研究对具有抗复制和非复制活性的新型芳基喹啉羧酸(QCA)进行了分析,()是 TB 的病原体。因此,对喹啉环中带有烷基、芳基、烷氧基、卤素和硝基的 48 种 QCA 进行了合成、表征和体外筛选(MABA 和 LORA),发现了两种带有 C-2 2-(萘-2-基)/C-6 1-丁基和 C-2 22-(菲-3-基)/C-6 异丙基的 QCA 衍生物,分别为最佳抑制剂。这两种化合物都显示出 DNA 拓扑异构酶抑制作用,其中 QCA 在高达 1 μM 的测试浓度下表现出更好的活性。最后,为两种化合物与 DNA 拓扑异构酶建立了对接模型,结果与体外结果具有良好的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/ec1f61b279dc/ijms-24-11632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/2bb5534d995a/ijms-24-11632-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/c1a4eacbd762/ijms-24-11632-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/95a3d5fdfdf9/ijms-24-11632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/ec1f61b279dc/ijms-24-11632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/2bb5534d995a/ijms-24-11632-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/c1a4eacbd762/ijms-24-11632-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/95a3d5fdfdf9/ijms-24-11632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/734b/10380224/ec1f61b279dc/ijms-24-11632-g002.jpg

相似文献

1
Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti- Gyrase Activity.基于芳基喹啉羧酸骨架的具有抗拓扑异构酶活性的抑制剂。
Int J Mol Sci. 2023 Jul 19;24(14):11632. doi: 10.3390/ijms241411632.
2
Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.设计、合成及抗结核活性的 4-烷氧基-三唑并喹诺酮能够抑制结核分枝杆菌 DNA 回旋酶。
Eur J Med Chem. 2019 Jan 1;161:399-415. doi: 10.1016/j.ejmech.2018.10.031. Epub 2018 Oct 17.
3
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.螺吡喃并嘧啶酮类 DNA 拓扑异构酶抑制剂具有强大且选择性的抗结核活性。
J Med Chem. 2022 May 12;65(9):6903-6925. doi: 10.1021/acs.jmedchem.2c00266. Epub 2022 May 2.
4
Synthesis, antimycobacterial activities and phototoxic evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic acid derivatives.5H-噻唑并[3,2-a]喹啉-4-羧酸衍生物的合成、抗分枝杆菌活性及光毒性评价
Med Chem. 2008 Sep;4(5):482-91. doi: 10.2174/157340608785700225.
5
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.苯并噻嗪酮 - 哌嗪衍生物作为高效的结核分枝杆菌DNA回旋酶抑制剂
Int J Mycobacteriol. 2015 Jun;4(2):104-15. doi: 10.1016/j.ijmyco.2015.02.002. Epub 2015 Mar 26.
6
Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis.基于结构的药物重定位以抑制结核分枝杆菌的 DNA 回旋酶。
Biochem J. 2020 Nov 13;477(21):4167-4190. doi: 10.1042/BCJ20200462.
7
Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.新型喹啉-氨基哌啶杂合类似物作为结核分枝杆菌DNA回旋酶B抑制剂的设计与合成
Bioorg Med Chem. 2015 May 1;23(9):2062-78. doi: 10.1016/j.bmc.2015.03.004. Epub 2015 Mar 9.
8
Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.新型2 -(取代基)-3 -氟/硝基-5,12 -二氢-5 -氧代苯并噻唑并[3,2 - a]喹啉-6 -羧酸的抗分枝杆菌活性
Bioorg Med Chem. 2008 Mar 15;16(6):3408-18. doi: 10.1016/j.bmc.2007.11.016. Epub 2007 Nov 9.
9
4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.4-氨基喹啉衍生物作为新型结核分枝杆菌GyrB抑制剂:结构优化、合成及生物学评价
Eur J Med Chem. 2015 Oct 20;103:1-16. doi: 10.1016/j.ejmech.2015.06.032. Epub 2015 Jun 15.
10
Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors.吖啶衍生物作为选择性结核分枝杆菌DNA回旋酶抑制剂的研发。
Bioorg Med Chem. 2016 Feb 15;24(4):877-85. doi: 10.1016/j.bmc.2016.01.011. Epub 2016 Jan 7.

引用本文的文献

1
DNA gyrase-inhibitory antimicrobial anthraquinone from the endophytic Sordariomycetes fungus Diaporthe perseae.来自内生粪壳菌纲真菌胡椒炭疽病菌的具有DNA促旋酶抑制活性的抗菌蒽醌
Arch Microbiol. 2025 Aug 28;207(10):239. doi: 10.1007/s00203-025-04429-6.
2
Synthesis, Characterisation, Biological Evaluation and In Silico Studies of Quinoline-1,2,3-Triazole-Anilines as Potential Antitubercular and Anti-HIV Agents.喹啉-1,2,3-三唑-苯胺作为潜在抗结核和抗艾滋病毒药物的合成、表征、生物学评价及计算机模拟研究
Molecules. 2025 May 10;30(10):2119. doi: 10.3390/molecules30102119.
3
Quinoline analogs: multifaceted heterocyclic compounds with varied synthetic strategies and potent antitubercular properties.

本文引用的文献

1
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.粘细菌衍生的环二肽软骨素通过靶向 SARS-CoV-2 的广谱、细胞趋向性刺突蛋白来阻断其进入细胞。
J Biomol Struct Dyn. 2022;40(22):12209-12220. doi: 10.1080/07391102.2021.1969281. Epub 2021 Aug 31.
2
Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)发病机制中至关重要的七种非结构蛋白具有计算机模拟抑制特性的抗HIV逆转录酶植物多酚类天然产物。
J Genet Eng Biotechnol. 2021 Jul 16;19(1):104. doi: 10.1186/s43141-021-00206-2.
3
喹啉类似物:具有多种合成策略和强大抗结核特性的多面杂环化合物。
RSC Adv. 2025 Feb 5;15(5):3646-3663. doi: 10.1039/d4ra08362h. eCollection 2025 Jan 29.
4
Identification of 2-(-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity.鉴定2-(-芳基-1,2,3-三唑-4-基)喹啉衍生物作为具有InhA抑制活性的抗结核药物。
Front Chem. 2024 Aug 7;12:1424017. doi: 10.3389/fchem.2024.1424017. eCollection 2024.
Potential Cancer- and Alzheimer's Disease-Targeting Phosphodiesterase Inhibitors from : Insights from and Consensus Virtual Screening.
来自[具体来源]的潜在靶向癌症和阿尔茨海默病的磷酸二酯酶抑制剂:基于[具体来源]和共识虚拟筛选的见解
ACS Omega. 2021 Mar 16;6(12):8403-8417. doi: 10.1021/acsomega.1c00137. eCollection 2021 Mar 30.
4
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.喹诺酮类药物:作用机制、致死性及其对抗生素耐药性的贡献。
Molecules. 2020 Dec 1;25(23):5662. doi: 10.3390/molecules25235662.
5
Antitubercular and cytotoxic polyoxygenated cyclohexane derivatives from .从 中分离得到的抗结核和细胞毒性多氧环己烷衍生物。
Nat Prod Res. 2021 Dec;35(23):5229-5232. doi: 10.1080/14786419.2020.1741579. Epub 2020 Mar 23.
6
Antitubercular and Cytotoxic Chlorinated seco-Cyclohexenes from Uvaria alba.从乌檀中提取出的具有抗结核和细胞毒性的氯代次环已烯。
J Nat Prod. 2017 Dec 22;80(12):3319-3323. doi: 10.1021/acs.jnatprod.7b00679. Epub 2017 Nov 27.
7
Microplate Alamar Blue Assay (MABA) and Low Oxygen Recovery Assay (LORA) for Mycobacterium tuberculosis.用于结核分枝杆菌的微孔板阿拉玛蓝测定法(MABA)和低氧复苏测定法(LORA)
Methods Mol Biol. 2015;1285:281-92. doi: 10.1007/978-1-4939-2450-9_17.
8
The use of resazurin as a novel antimicrobial agent against Francisella tularensis.利用试卤灵作为一种新型抗弗朗西斯菌药物。
Front Cell Infect Microbiol. 2013 Dec 6;3:93. doi: 10.3389/fcimb.2013.00093. eCollection 2013.
9
Synthesis of Substituted Isatins.取代异吲哚酮的合成。
Tetrahedron Lett. 2013 Feb 1;54(8):1008-1011. doi: 10.1016/j.tetlet.2012.12.035. Epub 2012 Dec 21.
10
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.老药新用:改造现有药物以优化耐药结核病治疗。
Clin Infect Dis. 2012 Aug;55(4):572-81. doi: 10.1093/cid/cis487. Epub 2012 May 21.